Skip to main content

Advertisement

Log in

Extra-pulmonary tuberculosis: a biomarker analysis

  • Clinical and Epidemiological Study
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Introduction

Studies on biomarkers in tuberculosis are focused on pulmonary forms of this disease (PTB), and only limited information is currently available on biomarkers of extra-pulmonary tuberculosis (EPTB).

Methods

Serum samples from 24 patients with PTB, 29 patients with EPTB and 27 healthy controls were obtained, and the levels of interferon-gamma, chemokine ligand 9, mannose-binding lectin (MBL), tumor marker Ca-125 and adenosine deaminase were determined.

Results

The circulating levels of all tested biomarkers in the serum were significantly higher in PTB and EPTB patients than in controls. However, there were no significant differences in the levels of the biomarkers between patients with PTB and EPTB, with the exception of serum levels of MBL which were significantly higher in patients with EPTB than in patients with PTB (p = 0.01). In patients with EPTB, no significant differences were observed in biomarker levels among patients with or without concomitant PTB involvement. Based on MBL serum levels, ROC curve analysis showed an AUC of 0.85 for EPTB versus non-EPTB. The optimal cut-off value of MBL serum levels for EPTB versus non-EPTB was 1,000 μg/ml, with a sensitivity and specificity of 79.3 and 78.0 %, respectively.

Conclusions

Biomarkers usually present as acute phase reactants and do not enable pulmonary forms to be differentiated from more serious or extra-pulmonary forms. MBL may be an exception.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extra-pulmonary tuberculosis in the United States, 1993–2006. Clin Infect Dis. 2009;49:1350–7.

    Article  PubMed  Google Scholar 

  2. Yang Z, Kong Y, Wilson F, Foxman B, Fowler AH, Marrs CF, et al. Identification of risk factors for extra-pulmonary tuberculosis. Clin Infect Dis. 2004;38:199–205.

    Article  PubMed  Google Scholar 

  3. Ilgazli A, Boyaci H, Basyigit I, Yildiz F. Extra-pulmonary tuberculosis: clinical and epidemiologic spectrum of 636 cases. Arch Med Res. 2004;35:435–41.

    Article  PubMed  Google Scholar 

  4. Sanz-Canalejas L, Gómez-Mampaso E, Cantón-Moreno R, Varona-Crespo C, Fortún J, Dronda F. Peliosis hepatis due to disseminated tuberculosis in a patient with AIDS. Infection. 2013;42:185–9.

    Google Scholar 

  5. Kim CH, Lim JK, Lee SY, Won DI, Cha SI, Park JY, Lee WK, Lee J. Predictive factors for tuberculosis in patients with a TB-PCR-negative bronchial aspirate. Infection. 2013;41:187–94. doi:10.1007/s15010-012-0394-7.

    Article  CAS  PubMed  Google Scholar 

  6. Jones BE, Young SM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis. 1993;148:1292–7.

    Article  CAS  PubMed  Google Scholar 

  7. Fortún J, Martín-Dávila P, Navas E, López-Vélez R, Pintado V, Cobo J, et al. Changes in the epidemiology of tuberculosis: the influence of international migration flows. Enferm Infecc Microbiol Clin. 2011;29:654–9.

    Article  PubMed  Google Scholar 

  8. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet. 2003;362:887–99.

    Article  PubMed  Google Scholar 

  9. Ameglio F, Giannarelli D, Cordiali-Fei P, et al. Use of discriminant analys is to assess disease activity in pulmonary tuberculosis with a panel of specific and non-specific serum markers. Am J Clin Pathol. 1994;101:719–25.

    CAS  PubMed  Google Scholar 

  10. Aoki Y, Katoh O, Nakanishi Y, et al. A comparison study of IFNgamma, ADA, and CA125 as the diagnostic parameters in tuberculous pleuritis. Respir Med. 1994;88:139–43.

    Article  CAS  PubMed  Google Scholar 

  11. Taha RA, Kotsimbos TC, Song YL, et al. IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis. Am J Respir Crit Care Med. 1997;155:1135–9.

    Article  CAS  PubMed  Google Scholar 

  12. Verbon A, Juffermans N, Van Deventer SJ, et al. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin Exp Immunol. 1999;115:110–3.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Cosar H, Ozkinay F, Onay H, Bayram N, Bakiler AR, Anil M, Ca D, Ozkinay C. Low levels of mannose-binding lectin confers protection against tuberculosis in Turkish children. Eur J Clin Microbiol Infect Dis. 2008;27:1165–9.

    Article  CAS  PubMed  Google Scholar 

  14. Fortún J, Martín-Davila P, Méndez R, Martínez A, Norman F, Rubi J, et al. Ca-125: a useful marker to distinguish pulmonary tuberculosis from other pulmonary infections. Open Respir Med J. 2009;3:123–7.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Capparelli R, Iannaccone M, Palumbo D, Medaglia C, Moscariello E, Russo A, Iannelli D. Role played by human mannose-binding lectin polymorphisms in pulmonary tuberculosis. J Infect Dis. 2009;199:666–72.

    Article  PubMed  Google Scholar 

  16. Hasan Z, Jamil B, Khan J, Ali R, Khan MA, Nasir N, Yusuf MS, Jamil S, Irfan M, Hussain R. Relationship between circulating levels of IFN-gamma, IL-10, CXCL9 and CCL2 in pulmonary and extrapulmonary tuberculosis is dependent on disease severity. Scand J Immunol. 2009;69:259–67.

    Article  CAS  PubMed  Google Scholar 

  17. Huang WC, Tseng CW, Chang KM, Hsu JY, Chen JH, Shen GH. Usefulness of tumor marker CA-125 serum levels for the follow-up of therapeutic responses in tuberculosis patients with and without serositis. Jpn J Infect Dis. 2011;64:367–72.

    CAS  PubMed  Google Scholar 

  18. Yilmaz A, Ece F, Bayramgürler B, Akkaya E, Baran R. The value of Ca 125 in the evaluation of tuberculosis activity. Respir Med. 2001;95:666–9.

    Article  CAS  PubMed  Google Scholar 

  19. Ad-hoc Committee of the Scientific Assembly on Microbiology, Tuberculosis, and Pulmonary Infections. Diagnostic standards and classification of tuberculosis in adults and children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000;161:1376–95.

    Google Scholar 

  20. Denholm JT, McBryde ES, Eisen DP. Mannose-binding lectin and susceptibility to tuberculosis: a meta-analysis. Clin Exp Immunol. 2010;162:84–90.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Huang WC, Tseng CW, Chang KM, Hsu JY, Chen JH, Shen GH. Usefulness of tumor marker CA-125 serum levels for the follow-up of therapeutic responses in tuberculosis patients with and without serositis. Jpn J Infect Dis. 2011;64:367–72.

    CAS  PubMed  Google Scholar 

  22. Yilmaz A, Ece F, Bayramgürler B, Akkaya E, Baran RB. The value of Ca 125 in the evaluation of tuberculosis activity. Respir Med. 2001;95:666–9.

    Article  CAS  PubMed  Google Scholar 

  23. Candocia SA, Locker GY. Elevated serum CA 125 secondary to tuberculous peritonitis. Cancer. 1993;72(6):2016–8.

    Article  CAS  PubMed  Google Scholar 

  24. Simsek H, Savas MC, Kadayifci A, et al. Elevated serum CA 125 concentration in patients with tuberculous peritonitis: a case-control study. Am J Gastroenterol. 1997;92:1174–6.

    CAS  PubMed  Google Scholar 

  25. Younossian AB, Rochat T, Favre L, Janssens JP. Ascites and highly elevated CA-125 levels in a case of peritoneal tuberculosis. Scand J Infect Dis. 2006;38:216–8.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Thomas O’Boyle for his assistance with the manuscript. This collaboration was supported by the Department of Infectious Diseases of Ramon y Cajal Hospital of Madrid, Spain.

Financial statement

There was no specific financial support for this study. Parts of this dataset were generated as during routine work at the Hospital Ramon y Cajal of Madrid, Spain.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Fortún.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fortún, J., Martín-Dávila, P., Gómez-Mampaso, E. et al. Extra-pulmonary tuberculosis: a biomarker analysis. Infection 42, 649–654 (2014). https://doi.org/10.1007/s15010-014-0602-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-014-0602-8

Keywords

Navigation